S&P 100
2.756,50
PKT
+37,31
PKT
+1,37
%
Werbung
Analysen zu S&P 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.06.12 | Oracle sector perform | RBC Capital Markets | |
| 01.06.12 | Accenture equal-weight | Barclays Capital | |
| 01.06.12 | Boeing buy | Goldman Sachs Group Inc. | |
| 31.05.12 | Visa neutral | UBS AG | |
| 31.05.12 | Medtronic buy | UBS AG | |
| 31.05.12 | Meta Platforms (ex Facebook) halten | Der Aktionär | |
| 31.05.12 | Apple overweight | Barclays Capital | |
| 31.05.12 | Walmart overweight | Barclays Capital | |
| 31.05.12 | Medtronic outperform | Oppenheimer & Co. Inc. | |
| 31.05.12 | Microsoft buy | Citigroup Corp. | |
| 31.05.12 | QUALCOMM overweight | Piper Jaffray & Co. | |
| 30.05.12 | Costco Wholesale hold | McAdams Wright Ragen Inc. | |
| 30.05.12 | Cisco outperform | Oppenheimer & Co. Inc. | |
| 30.05.12 | Apple buy | Société Générale Group S.A. (SG) | |
| 30.05.12 | QUALCOMM sector outperform | Scotia Capital Markets | |
| 30.05.12 | Apple outperform | RBC Capital Markets | |
| 30.05.12 | Verizon sector perform | RBC Capital Markets | |
| 30.05.12 | Intel kaufen | Hamburger Sparkasse AG (Haspa) | |
| 30.05.12 | Raytheon Technologies overweight | Barclays Capital | |
| 30.05.12 | Biogen outperform | RBC Capital Markets | |
| 30.05.12 | ExxonMobil buy | Goldman Sachs Group Inc. | |
| 30.05.12 | Biogen neutral | JP Morgan Chase & Co. | |
| 30.05.12 | Walt Disney overweight | Morgan Stanley | |
| 30.05.12 | ConocoPhillips buy | Citigroup Corp. | |
| 29.05.12 | Altria hold | Jefferies & Company Inc. | |
| 29.05.12 | Linde buy | Deutsche Bank AG | |
| 29.05.12 | Microsoft buy | UBS AG | |
| 29.05.12 | QUALCOMM buy | UBS AG | |
| 29.05.12 | Procter Gamble halten | Independent Research GmbH | |
| 29.05.12 | Apple overweight | Piper Jaffray & Co. | |
| 28.05.12 | CVS Health overweight | Barclays Capital | |
| 25.05.12 | MetLife sector perform | RBC Capital Markets | |
| 25.05.12 | HP outperform | RBC Capital Markets | |
| 25.05.12 | Johnson Johnson sector perform | RBC Capital Markets | |
| 25.05.12 | Gilead Sciences kaufen | Der Aktionär | |
| 25.05.12 | MetLife overweight | Barclays Capital | |
| 24.05.12 | Thermo Fisher Scientific buy | UBS AG | |
| 24.05.12 | HP equal-weight | Morgan Stanley | |
| 24.05.12 | Halliburton buy | UBS AG | |
| 24.05.12 | Coca-Cola overweight | Barclays Capital |